Active traders in the healthcare sector are anticipating significant share price spikes tied to new therapy developments and earnings reports. Companies like Abbott Laboratories (NYSE: ABT) are expected to show growth potential despite nutrition segment sluggishness. Intuitive Surgical (NASDAQ: ISRG) is also poised for growth, with strong fourth-quarter earnings and long-term prospects. Investors are watching for opportunities in both companies. Wall Street analysts have reiterated Buy ratings for both ABT and ISRG, with potential upside for investors.

Read more at Nasdaq: 2 Healthcare Names That Could Get a Big Boost From Earnings